These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36376892)

  • 1. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
    Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
    Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
    Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
    Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
    Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
    Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
    Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
    Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
    Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
    Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
    Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer.
    Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y
    Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation.
    Chen K; Zhang Z; Yu A; Li J; Liu J; Zhang X
    Biomed Res Int; 2020; 2020():6575724. PubMed ID: 33195697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.
    Bian Z; Zhou M; Cui K; Yang F; Cao Y; Sun S; Liu B; Gong L; Li J; Wang X; Li C; Yao S; Yin Y; Huang S; Fei B; Huang Z
    J Exp Clin Cancer Res; 2021 Nov; 40(1):360. PubMed ID: 34782005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
    Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
    BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
    Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
    J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
    Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
    Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
    Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
    J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
    J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
    Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
    Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DLGAP1-AS2 facilitates Wnt1 transcription through physically interacting with Six3 and drives the malignancy of gastric cancer.
    Lu J; Xu Y; Xie W; Tang Y; Zhang H; Wang B; Mao J; Rui T; Jiang P; Zhang W
    Cell Death Discov; 2021 Sep; 7(1):255. PubMed ID: 34545072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A.
    Lin J; Shi Z; Yu Z; He Z
    Biomed Pharmacother; 2018 Feb; 98():433-439. PubMed ID: 29278853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.